Sort
40,608 grants matching “prostate cancer”
RISK FACTORS FOR ADVANCED PROSTATE CANCER
$588,277University Of Southern California · R01 · FY2003 · CA
CHEMICAL AGONISTS OF THE PML/DAXX PATHWAY FOR PROSTATE CANCER THERAPY
$588,267Sanford Burnham Prebys Medical Discovery Institute · · FY2008 · Department of the Army
PET-determined prostate brachytherapy dosing using intraoperative image-guidance
$588,227Daniel Song · Johns Hopkins University · R01 · FY2020 · CA
A Sustainable Approach to Increasing Cancer Screening in Community Health Centers
$588,226Karen M Emmons · Dana-Farber Cancer Inst · R01 · FY2009 · CA
Research Infrastructure Core
$588,199Song Gao · Texas Southern University · U54 · FY2022 · MD
Elucidation of the mechanisms by which cells recognize and respond to different levels of androgens
$588,140Donald P McDonnell · Duke University · R01 · FY2025 · CA
Phase III Trial of Selenium for Prostate Cancer Prevention
$588,097Frederick R Ahmann · University Of Arizona · R01 · FY2008 · CA
Novel Approaches Targeting B7-H3 in Castration-resistant Prostate Cancer
$588,065Di Zhao · University Of Tx Md Anderson Can Ctr · R01 · FY2023 · CA
Novel Approaches Targeting B7-H3 in Castration-resistant Prostate Cancer
$588,065Di Zhao · University Of Tx Md Anderson Can Ctr · R01 · FY2025 · CA
Project 1 - Epigenetic Control of Normal and Malignant Neuroendocrine Differentiation
$588,058Ramesh A Shivdasani · Dana-Farber Cancer Inst · P01 · FY2025 · CA
Testing Effective Methods to Recruit Sexual and Gender Minority Cancer Patients for Cancer Studies
$588,034B. R. Simon Rosser · University Of Minnesota · R01 · FY2023 · CA
Clinical Translation of dual-modality transrectal ultrasound and photoacoustic imaging for detection of aggressive human prostate cancer
$588,018Sri Rajasekhar Kothapalli · Pennsylvania State University, The · R01 · FY2024 · CA
Technetium and Rhenium in Nuclear Medicine
$587,899Alun Gareth Jones · Harvard Medical School · R01 · FY2010 · CA
Reuse of ZD4054 for patients with symptomatic PAD
$587,704Brian H Annex · University Of Virginia · UH3 · FY2013 · TR
Reuse of ZD4054 for patients with symptomatic PAD
$587,704Brian H Annex · University Of Virginia · UH3 · FY2014 · TR
Hybrid Nanoparticles in Imaging and Therapy of Prostate*
$587,694Kattesh V Katti · University Of Missouri-Columbia · R01 · FY2007 · CA
GENE-ENVIRONMENT INTERACTIONS: THE ODYSSEY COHORT
$587,656Johns Hopkins University · U01 · FY2003 · AG
Internet-Based Lifestyle Intervention to Eradicate Obese Frailty in Prostate Cancer Survivors (iLIVE)
$587,585Kerri M Winters-Stone · Oregon Health & Science University · R01 · FY2023 · CA
GENE-ENVIRONMENT INTERACTIONS: THE ODYSSEY COHORT
$587,315Johns Hopkins University · U01 · FY2002 · AG
Improving Prostate Cancer Outcome Prediction Through Noninvasive exRNA Assessment
$587,298Matthew R Cooperberg · University Of California, San Francisco · R01 · FY2019 · CA
Glycoprotein biomarkers for the early detection of aggressive prostate cancer
$587,230Hui Zhang · Johns Hopkins University · U01 · FY2012 · CA
EARLY DETECTION OF PROSTATE CANCER WITH NEW NANOPARTICALES-BASED ULTRASOUND CONTRAST AGENTS TARGETED TO PSMA
$587,222Case Western Reserve University · · FY2016 · Department of Defense
KINASE INHIBITORS PRESENT EXCITING THERAPIES FOR CANCER INCLUDING PROSTATE CANCER.
$587,220University Of Washington · · FY2017 · Department of the Army
Genetics and Molecular Mechanisms of Prostate Cancer
$587,204William Douglas Figg · Division Of Basic Sciences - Nci · ZIA · FY2025 · CA
GENETICS OF PROSTATE CANCER SUSCEPTIBILITY
$587,183Fred Hutchinson Cancer Research Center · R01 · FY2000 · CA